Programme

The conference at a glance

Download the programme in PDF format

07:00 - 09:00

Registration and welcome coffee

09:00 - 13:00

Opening Plenary Session – Global health policy aspects about counterfeiting and traceability

09:00 - 09:30

Opening remarks and welcome to the conference

  • Moji Christianah Adeyeye, Ph.D, FAS, Director-General, NAFDAC (confirmed)
  • Representative of Ministry of Health (invited)
  • Miguel Lopera, CEO and President GS1 (invited)
09:30 - 10:45

Keynote Speeches

  • Tom Woods, World Bank (confirmed)
  • USAID (tbc)
  • Philippe François, Head of Sourcing and Supply Chain at the Global Fund (invited)
10:45 - 10:50

Photo moment

10:50 - 11:30

Coffee break

11:30 - 12:00

WHO efforts to prevent substandard and falsified medical products entering the global market

François-Xavier Lery, Coordinator for Technologies, Standards and norms [TSN]. Regulation of Medicines and Other Health Technologies [RHT] Department of Essential Medicines and Health Products [EMP] World Health Organization, Geneva, Switzerland (confirmed)

12:00 - 12:30

AMRH

Moji Christianah Adeyeye, Ph.D, FAS, Director-General, NAFDAC (confirmed)

12:30 - 12:55

NEPAD

Margaret Ndomondo-Sigonda, Head of Health Programs at the African Union-New Partnership for Africa's Development, NEPAD (confirmed)

12:55 - 13:00

Introduction to the afternoon sessions

13:00 - 14:30

General Networking lunch, visit of market place

14:30 - 15:45

Two parallel streams

  • Panel I – Government and regulatory body Think Tank - Learning from other countries and regions

    Open to international government healthcare organisations – discussions will be held under the Chatham House Rule

    • Facilitator: Géraldine Lissalde-Bonnet, Public Policy Director, GS1 Global Office, Belgium (confirmed)
  • Panel II – Establishing Traceability: the building blocks

    • Identify: Pfizer (confirmed)
    • Capture: (tbd)
    • Share: Janssen/J&J (confirmed)

    Each panellist will present 15’, followed by an open discussion and Q&A session

15:45 - 16:15

Coffee break

16:15 - 17:30

Two parallel streams

  • Panel I – Government and regulatory body Think Tank, continued - Learning from other countries and regions

    Open only to international government healthcare organisations on invitation – discussions will be held under the Chatham House Rule

    • Facilitator: Géraldine Lissalde-Bonnet, Public Policy Director, GS1 Global Office, Belgium (confirmed)
  • Panel II – Databases and infrastructure for traceability

    • Janssen
    • Ike Ofuani, Director Government Affairs, Johnson & Johnson, Nigeria (confirmed)
    • Francoise Hirth, Serialisation Coordinator for Europe and EEMEA, Roche (confirmed)
    • Pfizer (confirmed)

    Each panellist will present 15’, followed by an open discussion and Q&A session

08:30 - 09:00

Welcome coffee

09:00 - 13:10

Plenary session – Traceability implementation

09:00 - 09:20

Nigeria – strengthening supply chain security

NAFDAC, Nigeria (tbd)

09:20 - 09:40

Ethiopia – building an End to End Supply Chain with global standards

Heran Gerba, Director General, EFDA, Ethiopia (confirmed)

09:40 - 10:00

Medicines traceability for patient safety in Turkey

Dr. Hakkı Gürsöz, President of Turkish Medicines and Medical Devices Agency (TMMDA), Turkey (invited)

10:00 - 11:00

Roundtable on capacity building for traceability

Chaired by Alan Bornbusch, Division Chief Commodity Security and Logistics Division, USAID (confirmed)

11:00 - 11:30

Coffee break

11:30 - 11:50

Dr. Seth Berkley, CEO, GAVI

(invited)

11:50 - 12:10

Ken Legins, UNICEF

(invited)

12:10 - 12:30

A controlled vaccine supply chain in Gambia

Pascal Aulagnet, Market Customer Engagement EMEA, Pfizer, France (confirmed)

12:30 - 12:50

The EU Falsified Medicines Directive

Francoise Hirth, Serialisation Coordinator for Europe and EEMEA, Roche (confirmed)

12:50 - 13:10

DSCSA – traceability regulation in the USA

US FDA (invited)

13:10 - 14:15

General networking lunch, visit of market place

14:15 - 15:45

Two parallel streams

  • Panel I – Government and regulatory body Think Tank – Discussing the possibility of regulatory alignment across Africa

    Open only to international government healthcare organisations on invitation – discussions will be held under the Chatham House Rule

    • Facilitator: Géraldine Lissalde-Bonnet, Public Policy Director, GS1 Global Office, Belgium (confirmed)
  • Panel II – Traceability – global status – developments worldwide

    • Dr. Winnie Mwangi, Regulatory Affairs Manager, GSK / Executive Secretary, KAPI (Kenya Association of Pharmaceutical Industry) (confirmed)
    • Senthil S. Rajaratnam, Lilly (invited)
15:45 - 16:15

Coffee break

16:15 - 17:45

Two parallel streams

  • Panel I – Government and regulatory body Think Tank, continued – Discussing the possibility of regulatory alignment across Africa

    Open only to international government healthcare organisations on invitation – discussions will be held under the Chatham House Rule

    • Facilitator: Geraldine Lissalde-Bonnet, Public Policy Director, GS1 Global Office, Belgium (confirmed)
  • Panel II – Data as the base for the supply chain

    (TBD)

08:30 - 09:00

Welcome coffee

09:00 - 13:30

The healthcare industry stakeholder perspective

09:00 - 09:30

Pranay Godha, CEO, IPCA Laboratories, India

(invited)

09:30 - 10:00

Mark Guttmann, Global Director Serialisation, Mylan

(invited)

10:00 - 10:30

Francoise Hirth, Serialisation Coordinator for Europe and EEMEA, Roche

(confirmed)

10:30 - 11:00

Yetunde O. Adigun, Head, Pharma Plant Operations, May & Baker

(confirmed)
11:00 - 11:45

Coffee break

11:45 - 12:15

Scan4safety - Helping the NHS save thousands of lives and millions of pounds

Cara Charles-Barks, CEO, Salisbury NHS Foundation Trust, UK (confirmed)

12:15 - 12:45

Closing keynote speech

(tbc)

12:45 - 13:15

Closing remarks

(tbc)

13:15 - 14:30

General networking lunch, visit of market place

14:30 - 16:30

Q&A with the Experts

Session for open question for everybody - table discussions